LED Medical Diagnostics Inc. (“LED Medical”) is the pioneer and global leader in tissue fluorescence visualization technologies for the medical industry.
Through its wholly-owned subsidiary, LED Dental Inc., the company manufactures the VELscope Vx Enhanced Oral Assessment System, the first system in the world to apply tissue fluorescence visualization technology to the oral cavity. VELscope Vx devices are now used worldwide to conduct more screenings for oral cancer and other oral diseases than any other adjunctive device.
Patented Tissue Fluorescence Visualization Technology
To-date, the tissue fluorescence visualization technology utilized by LED Medical has benefitted from over $50MM in research funded by the National Institutes of Health and other foundations and institutions both in the US and Canada. The British Columbia Cancer Agency (“BCCA”) was a partner with LED Medical in developing a means of applying this technology to the oral cavity; the agency now receives a royalty on VELscope Vx sales revenues. An additional, $20MM plus was invested into the company prior to it going public in November.
Major Inroads into the Dental Industry
So far, VELscope Vx Enhanced Oral Assessment Systems are being used by dentists in 23 countries. More than 12,000 VELscope Vx systems have been used to perform over 25 million exams. The technology is FDA and Health Canada approved, has been recognized by The World Health Organization, and has twice been named “Best of Class” by the prestigious Pride Institute. For more information, visit